HOT Research
Determination of melanoma thickness via optoacoustics and optical coherence tomography (OCT)

Determination of melanoma thickness via optoacoustics and optical coherence tomography (OCT)

Led by:  B. Roth, M. Wollweber, U. Morgner, M. Rahlves
Year:  2013
Funding:  BMBF

Determination of melanoma thickness via optoacoustics and optical coherence tomography (OCT)

Skin cancer is the most common type of cancer. The most dangerous form of skin cancer is malignant melanoma. It is one of the most dangerous forms of all types of cancer as its risk to metastasize is very high at later tumor stages. On the other hand, it can be identified and fully cured fairly easily at early stages. The invasion depth of the malignant cells marks the tumor stage and is an important factor for the patient’s prognosis. It is routinely determined by histopathology after biopsy. Optical determination of the tumor thickness would be highly beneficial as it allows better to evaluate the tumor stage at a first visit in advance to surgical measures and to adjust therapy accordingly.

In this view, research within this project is aimed at the development and validation of a method for presurgical assessment of melanoma thickness. In a first project stage, an approach combining different optical methods was realized. In a second stage, the system is to be further advanced for application and validation in a clinical environment. At the final stage of development, the system shall be capable to preoperatively measure the tumor thickness with an accuracy in the order of 50 µm and provide the attending dermatologist with morphological and spectroscopic information to support diagnosis of melanoma skin cancer.

This VIP project sets the technical and methodological foundations for this goal by developing a demonstrator and characterizing the multi-method system and validating the method. In a subsequent development project, the concept will then be implemented in cooperation with partners from business and medicine into a marketable device.